Data Monitoring Committee: "A Phase 3 randomized, multicenter, multinational, double-blinded study comparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) and alglucosidase alfa in treatment-naive patients with late
|Effective start/end date||2/15/19 → 12/31/24|
- SANOFI-AVENTIS US
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.